Topics discussed will include The Impact of the COVID-19 Pandemic on TB Numbers and Deaths, Non-HIV TB Related Immune Reconstitution Inflammatory Syndrome (IRIS), Study 31 Implementation – Important Considerations, New Terminology for XDR-TB, Listening to Patient Voices.